Giving Cardiovascular Clinicians a Voice in Evidence Generation: A Collaboration Between FDA and JACC
∗Address for correspondence: Dr Robert M. Califf, Commissioner of Food and Drugs, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, Maryland 20903, USA. E-mail: E-mail Address: [email protected] The health care system in the United States is failing short of the health outcomes that the American public deserves, despite massive investments and incurred costs. 1 This underperformance is particularly noteworthy for patients with cardiovascular disease (CVD), given the scientific
